SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Intersect ENT, Inc. (XENT) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 25/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — XENT
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio8.80
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-4.80
Book Value / Share$0.00
Revenue / Share$3.21
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$-0.94 |
$5.86M |
$-16.37M |
-279.1% |
| 2013 |
$-1.17 |
$17.93M |
$-18.37M |
-102.4% |
| 2014 |
$-1.61 |
$38.59M |
$-18.36M |
-47.6% |
| 2015 |
$-1.02 |
$61.59M |
$-26.63M |
-43.2% |
| 2016 |
$-0.89 |
$78.71M |
$-25.22M |
-32% |
| 2017 |
$-0.56 |
$96.3M |
$-16.36M |
-17% |
| 2018 |
$-0.76 |
$108.47M |
$-22.92M |
-21.1% |
| 2019 |
$-1.37 |
$109.14M |
$-42.99M |
-39.4% |
| 2020 |
$-2.22 |
$80.55M |
$-72.32M |
-89.8% |
| 2021 |
$-4.80 |
$106.75M |
$-159.64M |
-149.5% |
